Methyl-indole inhibits pancreatic cancer cell viability by down-regulating ZFX expression

Area of Science:

• Oncology
• Molecular Biology
• Pharmacology

Background:

• Pancreatic cancer remains a leading cause of cancer-related mortality with limited effective therapeutic options.
• Identifying novel compounds with anti-cancer properties is crucial for developing new treatment strategies.

Purpose of the Study:

• To investigate the anti-proliferative and apoptotic effects of methyl-indole on pancreatic cancer cells.
• To elucidate the underlying molecular mechanisms, including the involvement of ZFX and the PI3K/AKT pathway.

Main Methods:

• Cell viability assays were performed on Capan-1, Aspc-1, and MIApaCa-2 cells treated with varying concentrations of methyl-indole.
• Apoptosis levels were assessed using flow cytometry.
• Western blotting and qRT-PCR were used to evaluate the expression of key proteins and mRNA, including PI3K, p-Akt, and ZFX.

Main Results:

• Methyl-indole demonstrated a dose-dependent suppression of pancreatic cancer cell viability.
• Treatment with 5 µM methyl-indole significantly reduced cell viability and increased apoptosis in all tested cell lines.
• Methyl-indole inhibited the expression of PI3K, p-Tyr, p-Crkl, and p-Akt, and suppressed ZFX mRNA and protein levels.

Conclusions:

• Methyl-indole exhibits significant anti-proliferative and pro-apoptotic effects on pancreatic cancer cells.
• The compound exerts its effects by targeting ZFX expression and down-regulating the PI3K/AKT signaling pathway.
• Methyl-indole represents a potential therapeutic agent for pancreatic cancer, warranting further investigation.